Bio-Rad Laboratories, Inc.
| Security | BIO / Bio-Rad Laboratories, Inc. |
| Insider | Colleen Corey |
This page shows the track record and history of COREY COLLEEN
insider trades in Bio-Rad Laboratories, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Colleen Corey in BIO / Bio-Rad Laboratories, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Colleen Corey in BIO / Bio-Rad Laboratories, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-03 | 2025-09-01 | 4 | COREY COLLEEN | BIO BIO.B | Bio-Rad A Common Stock | D | 297.8800 | -398 | -119 | 19,183 | ||||
| 2025-09-03 | 2025-09-01 | 4 | COREY COLLEEN | BIO BIO.B | Bio-Rad A Common Stock | D | 1,102 | 19,581 | ||||||
| 2024-09-04 | 2024-09-03 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 334.3100 | -177 | -59 | 18,479 | ||||
| 2024-09-04 | 2024-09-03 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 495 | 18,656 | ||||||
| 2024-09-04 | 2024-09-02 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 337.3200 | -129 | -44 | 18,161 | ||||
| 2024-09-04 | 2024-09-02 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 361 | 18,290 | ||||||
| 2024-09-04 | 2024-09-01 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 337.3200 | -91 | -31 | 17,929 | ||||
| 2024-09-04 | 2024-09-01 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 253 | 18,020 | ||||||
| 2024-09-04 | 2024-09-01 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 337.3200 | -124 | -42 | 17,767 | ||||
| 2024-09-04 | 2024-09-01 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 347 | 17,891 | ||||||
| 2024-09-04 | 2024-09-01 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 337.3200 | -179 | -60 | 17,544 | ||||
| 2024-09-04 | 2024-09-01 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 500 | 17,723 | ||||||
| 2023-09-06 | 2023-09-04 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 394.6000 | -208 | -82 | 17,223 | ||||
| 2023-09-06 | 2023-09-04 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 600 | 17,431 | ||||||
| 2023-09-06 | 2023-09-03 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 394.6000 | -172 | -68 | 16,831 | ||||
| 2023-09-06 | 2023-09-03 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 495 | 17,003 | ||||||
| 2023-09-06 | 2023-09-02 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 394.6000 | -125 | -49 | 16,508 | ||||
| 2023-09-06 | 2023-09-02 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 361 | 16,633 | ||||||
| 2023-09-06 | 2023-09-01 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 394.6000 | -88 | -35 | 16,272 | ||||
| 2023-09-06 | 2023-09-01 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 253 | 16,360 | ||||||
| 2023-09-06 | 2023-09-01 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 394.6000 | -120 | -47 | 16,107 | ||||
| 2023-09-06 | 2023-09-01 | 4 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 347 | 16,227 | ||||||
| 2023-05-04 | 3 | COREY COLLEEN | BIO BIOB | Bio-Rad A Common Stock | D | 15,880 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
